title: The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone.
abstract: Mitoquinone (MitoQ) is a synthetically modified, redox-active ubiquinone compound that accumulates predominantly in mitochondria. We found that MitoQ is 30-fold more cytotoxic to breast cancer cells than to healthy mammary cells. MitoQ treatment led to irreversible inhibition of clonogenic growth of breast cancer cells through a combination of autophagy and apoptotic cell death mechanisms. Relatively limited cytotoxicity was seen with the parent ubiquinone coenzyme Q(10.) Inhibition of cancer cell growth by MitoQ was associated with G(1)/S cell cycle arrest and phosphorylation of the checkpoint kinases Chk1 and Chk2. The possible role of oxidative stress in MitoQ activity was investigated by measuring the products of hydroethidine oxidation. Increases in ethidium and dihydroethidium levels, markers of one-electron oxidation of hydroethidine, were observed at cytotoxic concentrations of MitoQ. Keap1, an oxidative stress sensor protein that regulates the antioxidant transcription factor Nrf2, underwent oxidation, degradation, and dissociation from Nrf2 in MitoQ-treated cells. Nrf2 protein levels, nuclear localization, and transcriptional activity also increased following MitoQ treatment. Knockdown of Nrf2 caused a 2-fold increase in autophagy and an increase in G(1) cell cycle arrest in response to MitoQ but had no apparent effect on apoptosis. The Nrf2-regulated enzyme NQO1 is partly responsible for controlling the level of autophagy. Keap1 and Nrf2 act as redox sensors for oxidative perturbations that lead to autophagy. MitoQ and similar compounds should be further evaluated for novel anticancer activity.
authors.affiliation: Laboratory of Biochemistry, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA. ashutosh.rao@fda.hhs.gov
authors.forename: V Ashutosh
authors.initials: VA
authors.lastname: Rao
authors.forename: Sarah R
authors.initials: SR
authors.lastname: Klein
authors.forename: Spencer J
authors.initials: SJ
authors.lastname: Bonar
authors.forename: Jacek
authors.initials: J
authors.lastname: Zielonka
authors.forename: Naoko
authors.initials: N
authors.lastname: Mizuno
authors.forename: Jennifer S
authors.initials: JS
authors.lastname: Dickey
authors.forename: Paul W
authors.initials: PW
authors.lastname: Keller
authors.forename: Joy
authors.initials: J
authors.lastname: Joseph
authors.forename: Balaraman
authors.initials: B
authors.lastname: Kalyanaraman
authors.forename: Emily
authors.initials: E
authors.lastname: Shacter
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects* / Q000235:genetics; D001343:Autophagy / Q000187:drug effects* / Q000235:genetics; D045744:Cell Line, Tumor; D000071877:Checkpoint Kinase 1; D064447:Checkpoint Kinase 2; D003603:Cytotoxins / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000494:pharmacology; D016193:G1 Phase / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D000072019:Kelch-Like ECH-Associated Protein 1; D051267:NF-E2-Related Factor 2 / Q000235:genetics / Q000378:metabolism*; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects / Q000235:genetics; D010617:Phenanthridines / Q000494:pharmacology; D011494:Protein Kinases / Q000235:genetics / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D016196:S Phase / Q000187:drug effects / Q000235:genetics; D014451:Ubiquinone / Q000494:pharmacology* / Q000031:analogs & derivatives
chemical_list: D000970:Antineoplastic Agents; D003603:Cytotoxins; D005456:Fluorescent Dyes; D047908:Intracellular Signaling Peptides and Proteins; C431364:KEAP1 protein, human; D000072019:Kelch-Like ECH-Associated Protein 1; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D009943:Organophosphorus Compounds; D010617:Phenanthridines; D014451:Ubiquinone; C058428:hydroethidine; C429014:mitoquinone; D011494:Protein Kinases; D064447:Checkpoint Kinase 2; C000605867:CHEK1 protein, human; C578634:CHEK2 protein, human; D000071877:Checkpoint Kinase 1; D017346:Protein Serine-Threonine Kinases
references.citation: J Biol Chem. 1985 Nov 5;260(25):13844-50
references.pmid: 4055760
references.citation: Mitochondrion. 2007 Jun;7 Suppl:S94-102
references.pmid: 17449335
references.citation: Free Radic Biol Med. 2005 Aug 1;39(3):403-11
references.pmid: 15993339
references.citation: J Biol Chem. 1998 Mar 27;273(13):7382-9
references.pmid: 9516435
references.citation: Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
references.pmid: 17717517
references.citation: Autophagy. 2008 Feb;4(2):246-8
references.pmid: 18094624
references.citation: Science. 1956 Aug 10;124(3215):269-70
references.pmid: 13351639
references.citation: J Biol Chem. 2001 Feb 16;276(7):4588-96
references.pmid: 11092892
references.citation: Antioxid Redox Signal. 2007 Nov;9(11):1825-36
references.pmid: 17854275
references.citation: Biochem J. 2005 Jul 15;389(Pt 2):527-39
references.pmid: 15799720
references.citation: Sci STKE. 2006 Oct 24;2006(358):pe44
references.pmid: 17062895
references.citation: Mol Cell Biol. 2003 Nov;23(22):8137-51
references.pmid: 14585973
references.citation: Ann N Y Acad Sci. 2002 Apr;959:263-74
references.pmid: 11976201
references.citation: Can J Physiol Pharmacol. 2010 Mar;88(3):285-95
references.pmid: 20393593
references.citation: Biol Pharm Bull. 2007 May;30(5):859-64
references.pmid: 17473426
references.citation: Mol Cell Biol. 2005 Oct;25(20):8925-37
references.pmid: 16199871
references.citation: Antioxid Redox Signal. 2009 Apr;11(4):777-90
references.pmid: 18828708
references.citation: Chem Res Toxicol. 2005 Dec;18(12):1917-26
references.pmid: 16359182
references.citation: Mol Cell Biol Res Commun. 2000 Jul;4(1):37-42
references.pmid: 11152626
references.citation: Cancer Res. 2007 Oct 15;67(20):9971-9
references.pmid: 17942930
references.citation: J Biol Chem. 1991 Sep 15;266(26):17707-12
references.pmid: 1832676
references.citation: Am J Physiol Cell Physiol. 2005 Jun;288(6):C1440-50
references.pmid: 15647387
references.citation: Free Radic Biol Med. 2009 Feb 1;46(3):329-38
references.pmid: 19026738
references.citation: Mol Cell Biol. 2009 Jan;29(2):493-502
references.pmid: 19001094
references.citation: Mol Cell Biol. 2004 Dec;24(24):10941-53
references.pmid: 15572695
references.citation: Cancer Res. 2008 Nov 15;68(22):9348-57
references.pmid: 19010909
references.citation: Oncogene. 2005 Feb 3;24(6):980-91
references.pmid: 15592527
references.citation: Cell Cycle. 2007 Sep 15;6(18):2263-7
references.pmid: 17890908
references.citation: Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):1028-31
references.pmid: 18439417
references.citation: J Biol Chem. 1988 Sep 25;263(27):13572-8
references.pmid: 2843525
references.citation: Methods Mol Biol. 2008;445:29-76
references.pmid: 18425442
references.citation: J Cell Sci. 2007 Dec 1;120(Pt 23):4155-66
references.pmid: 18032788
references.citation: Methods Enzymol. 2004;382:115-44
references.pmid: 15047100
references.citation: Cancer Res. 2001 Jan 15;61(2):439-44
references.pmid: 11212227
references.citation: Br J Pharmacol. 2006 Feb;147(3):239-48
references.pmid: 16331284
references.citation: Trends Cell Biol. 2008 Apr;18(4):165-73
references.pmid: 18296052
references.citation: Autophagy. 2008 Feb;4(2):151-75
references.pmid: 18188003
references.citation: Trends Biotechnol. 1997 Aug;15(8):326-30
references.pmid: 9263481
references.citation: J Biol Chem. 2004 Sep 3;279(36):37575-87
references.pmid: 15220329
references.citation: J Biol Chem. 2005 Aug 26;280(34):30091-9
references.pmid: 15983046
references.citation: Mol Cell Biol. 2007 Apr;27(7):2572-81
references.pmid: 17242188
references.citation: Science. 1982 Dec 10;218(4577):1117-9
references.pmid: 7146897
references.citation: Arch Biochem Biophys. 2007 Jun 15;462(2):245-53
references.pmid: 17475204
references.citation: Autophagy. 2007 Nov-Dec;3(6):542-5
references.pmid: 17611390
references.citation: Mol Cell Biol. 2002 Sep;22(18):6521-32
references.pmid: 12192050
references.citation: Cancer Res. 2003 May 1;63(9):2103-8
references.pmid: 12727826
references.citation: Free Radic Biol Med. 2007 Jun 1;42(11):1690-703
references.pmid: 17462537
references.citation: Autophagy. 2007 Sep-Oct;3(5):433-41
references.pmid: 17471016
references.citation: Biophys J. 2009 Feb 18;96(4):1388-98
references.pmid: 19217856
references.citation: Methods Mol Biol. 2007;369:143-73
references.pmid: 17656750
references.citation: J Biol Chem. 2008 Jul 4;283(27):18678-84
references.pmid: 18434300
references.citation: J Biol Chem. 2006 Dec 8;281(49):37416-26
references.pmid: 17040906
references.citation: Free Radic Biol Med. 2008 Mar 1;44(5):835-46
references.pmid: 18155177
references.citation: Cell Death Differ. 2007 Mar;14(3):500-10
references.pmid: 16990848
references.citation: J Biol Chem. 2006 Nov 3;281(44):33684-96
references.pmid: 16920718
references.citation: Mol Carcinog. 2009 Feb;48(2):91-104
references.pmid: 18618599
references.citation: Nat Protoc. 2008;3(1):8-21
references.pmid: 18193017
references.citation: Autophagy. 2005 Jul;1(2):84-91
references.pmid: 16874052